Here’s What Happened at Probiota, 13-15 February in Copenhagen
Probiota Copenhagen 2019 broke a new record, going from 250 attendees last year to 350 and sold out! Why? Because of its unique approach to bringing together stakeholders from the industry, the academy, CROs and […]
Kaleido Biosciences Announces Pricing of Initial Public Offering
Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, announced the pricing of its initial […]
Pivot Bio Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2019
Pivot Bio announced it is named to Fast Company’s annual list of the World’s Most Innovative Companies in 2019. The company was recognized for its transformational work in agriculture, earning Pivot Bio the eighth spot […]
Axial Biotherapeutics Raises $25 Million in Series B Financing
Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative and neuropsychiatric diseases, today announced the completion of a $25 million series B equity financing. New investor Seventure Partners, […]
Acurx Announces First-In-Man Clinical Trial Data of ACX-362E for CDI
Acurx Pharmaceuticals, LLC (“Acurx” or the “Company”), a privately-held, clinical stage, biopharmaceutical company developing new antibiotics for difficult-to-treat bacterial infections, announced today that its lead product candidate, ACX-362E, has successfully completed the 32-subject, double-blinded, placebo-controlled, […]
KNOW Bio Announces Creation of Digestive Health Therapeutics, Inc.
KNOW Bio, LLC., (the Company), a North Carolina developer of nitric oxide-based medical technology and related biotechnology companies, announced that the Company has formed a new wholly-owned operating subsidiary, Digestive Health Therapeutics, Inc, to develop […]
DuPont Nutrition & Health and Lonza Specialty Ingredients Announce Joint Agreement in Human Milk Oligosaccharides
DuPont Nutrition & Health and Lonza Specialty Ingredients announce an agreement under which the leading biotechnology and specialty ingredient company Lonza will manufacture and supply CARE4U™ 2’-FL – a human milk oligosaccharide (HMOs). This strategic […]